GR3007136T3 - - Google Patents

Info

Publication number
GR3007136T3
GR3007136T3 GR920403127T GR920403127T GR3007136T3 GR 3007136 T3 GR3007136 T3 GR 3007136T3 GR 920403127 T GR920403127 T GR 920403127T GR 920403127 T GR920403127 T GR 920403127T GR 3007136 T3 GR3007136 T3 GR 3007136T3
Authority
GR
Greece
Prior art keywords
polyalcohol
derivatised
protein
polyalcohols
recognised
Prior art date
Application number
GR920403127T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3007136T3 publication Critical patent/GR3007136T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Radiation-Therapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
GR920403127T 1989-04-19 1993-02-25 GR3007136T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3912792A DE3912792A1 (de) 1989-04-19 1989-04-19 Konjugate zur tumorlokalisation und/oder tumortherapie, verfahren zu ihrer herstellung sowie diese enthaltende diagnostika und/oder therapeutika

Publications (1)

Publication Number Publication Date
GR3007136T3 true GR3007136T3 (el) 1993-07-30

Family

ID=6378961

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920403127T GR3007136T3 (el) 1989-04-19 1993-02-25

Country Status (7)

Country Link
EP (1) EP0398024B1 (el)
JP (1) JPH0819156B2 (el)
AT (1) ATE85894T1 (el)
DE (2) DE3912792A1 (el)
DK (1) DK0398024T3 (el)
ES (1) ES2054137T3 (el)
GR (1) GR3007136T3 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4334317A1 (de) * 1993-10-08 1995-04-13 Dombaj Gmbh Vorrichtung zur Trennung von dissoziierte Stoffe enthaltenden Flüssigkeitsströmen
DE4435087A1 (de) * 1994-09-30 1996-04-04 Deutsches Krebsforsch Konjugat zur Behandlung von Infektions-, Autoimmun- und Hauterkrankungen
GB0609370D0 (en) * 2006-05-11 2006-06-21 Mock Graham A Process for cross-linking macromolecules
JP2010054305A (ja) * 2008-08-27 2010-03-11 Tohoku Denshi Sangyo Kk 癌罹病の検定に使用するデータの収集方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466951A (en) * 1982-11-12 1984-08-21 University Of California Intracellular trapping of therapeutics or tracer agents

Also Published As

Publication number Publication date
ATE85894T1 (de) 1993-03-15
DK0398024T3 (da) 1993-03-29
ES2054137T3 (es) 1994-08-01
EP0398024B1 (de) 1993-02-24
JPH0819156B2 (ja) 1996-02-28
DE3912792A1 (de) 1990-10-25
JPH0334999A (ja) 1991-02-14
DE59000908D1 (de) 1993-04-01
EP0398024A1 (de) 1990-11-22

Similar Documents

Publication Publication Date Title
Hussain et al. Modern diagnostic imaging technique applications and risk factors in the medical field: a review
Cassidy et al. Molecular imaging perspectives
BR9708470A (pt) Agentes de contraste bioativados para formação de imagem para diagnósticos
DE102005029270B4 (de) Katheter, Kathetereinrichtung und bildgebende Diagnosevorrichtung
DE102005053994A1 (de) Diagnosevorrichtung für kombinierte und/oder kombinierbare radiographische und nuklearmedizinische Untersuchungen sowie entsprechendes Diagnoseverfahren
DE102005027951A1 (de) Medizinisches System zur Einführung eines Katheters in ein Gefäß
Umutlu et al. Whole-body [18F]-FDG-PET/MRI for oncology: a consensus recommendation
Lois et al. Effect of MR contrast agents on quantitative accuracy of PET in combined whole-body PET/MR imaging
Graeser et al. Design of a head coil for high resolution mouse brain perfusion imaging using magnetic particle imaging
Youn et al. In vivo non invasive molecular imaging for immune cell tracking in small animals
Tang et al. Imaging radiation-induced gastrointestinal, bone marrow injury and recovery kinetics using 18F-FDG PET
WO2015161033A1 (en) Photon counting computed tomography using a combination of contrast agents for simultaneous visualization of anatomy and a plurality of materials
GR3007136T3 (el)
Iftimia et al. Advances in Optical Imaging for Clinical Medicine
Prasad et al. Imaging Techniques in Veterinary Disease Diagnosis
KR101126047B1 (ko) Ｐｅｔ－ｍｒｉ 시스템의 ｐｅｔ 장치를 위한 ｒｆ 차폐박스
Zheng et al. Magnetic particle imaging
CA2480641A1 (en) Passive movement of a patient within a magnetic resonance tomograph
Shi et al. Evolution from Medical Imaging to Visualized Medicine
Weber et al. Evaluation of 68Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate Cancer patients using the digital biograph vision
Parker et al. The use of a semiconductor probe for dose-rate measurements during intracavitary irradiation
US20050238583A1 (en) Contrast agent specifically suitable for X-ray computed tomography
Weston et al. Imaging for anaesthetists: a review of the methods and anaesthetic implications of diagnostic imaging techniques
Freeman et al. Nuclear Medicine Annual 1989
Laganovskis et al. Diagnostic information value and radiation load on the patient of retrograde cholangiopancreatography and computed tomography of the pancreas